Biotecnologia
119 empresas desta indústria listadas nos EUA.
Empresas
119 listadas
| Empresa | Receita | Lucro líquido | Margem | ROE | Receita 5a | Anos |
|---|---|---|---|---|---|---|
| AMGNAMGEN INC | $36,75 bi | $7,71 bi | 21.0% | 106.1% | +7.6% | 19 |
| GILDGILEAD SCIENCES, INC. | $29,44 bi | $8,51 bi | 28.9% | 40.5% | +3.6% | 19 |
| BIIBBIOGEN INC. | $9,89 bi | $1,29 bi | 13.1% | 7.4% | -6.0% | 19 |
| ARGXARGENX SE | $4,15 bi | $1,29 bi | 31.1% | 20.2% | +151.5% | 11 |
| NBIXNEUROCRINE BIOSCIENCES INC | $2,86 bi | $478,6 mi | 16.7% | 16.4% | +22.3% | 17 |
| EXELEXELIXIS, INC. | $2,32 bi | $782,6 mi | 33.7% | 35.5% | +18.6% | 17 |
| QGENQIAGEN N.V. | $2,09 bi | $424,9 mi | 20.3% | 11.6% | +2.2% | 18 |
| MRNAModerna, Inc. | $1,94 bi | -$2,82 bi | -145.2% | -28.9% | +19.3% | 10 |
| HALOHALOZYME THERAPEUTICS, INC. | $1,40 bi | $316,9 mi | 22.7% | 153.6% | +39.2% | 17 |
| TECHBIO-TECHNE Corp | $1,22 bi | $181,9 mi | 15.0% | 9.0% | +5.5% | 18 |
| NVAXNOVAVAX INC | $1,12 bi | $440,3 mi | 39.2% | · | +18.8% | 16 |
| BCRXBIOCRYST PHARMACEUTICALS INC | $874,8 mi | $263,9 mi | · | · | +117.9% | 17 |
| RGENREPLIGEN CORP | $738,3 mi | $48,9 mi | 6.6% | 2.4% | +15.0% | 16 |
| ALVOAlvotech | $586,3 mi | $27,9 mi | 4.8% | · | +54.5% | 6 |
| ADMAADMA BIOLOGICS, INC. | $510,2 mi | $146,9 mi | 28.8% | 35.6% | +64.6% | 15 |
| TARSTarsus Pharmaceuticals, Inc. | $451,4 mi | -$66,4 mi | -14.7% | -23.4% | · | 6 |
| KRYSKrystal Biotech, Inc. | $389,1 mi | $204,8 mi | 52.6% | 18.9% | · | 5 |
| TWSTTwist Bioscience Corp | $376,6 mi | -$77,7 mi | -20.6% | -16.4% | +33.1% | 9 |
| ADPTAdaptive Biotechnologies Corp | $277,0 mi | -$59,5 mi | -21.5% | -28.2% | +23.0% | 9 |
| VCELVericel Corp | $276,3 mi | $16,5 mi | 6.0% | 5.1% | +17.3% | 17 |
| BEAMBeam Therapeutics Inc. | $139,7 mi | -$80,0 mi | -57.2% | -8.1% | +466.3% | 7 |
| IBRXImmunityBio, Inc. | $113,3 mi | -$351,4 mi | -310.2% | · | +184.8% | 13 |
| RXRXRECURSION PHARMACEUTICALS, INC. | $74,7 mi | -$644,8 mi | -863.4% | -59.5% | +79.9% | 7 |
| VIRVir Biotechnology, Inc. | $68,6 mi | -$438,0 mi | -638.9% | -45.7% | -2.1% | 9 |
| KYMRKymera Therapeutics, Inc. | $39,2 mi | -$311,4 mi | -794.0% | -25.8% | +2.9% | 7 |
| MESOMESOBLAST LTD | $17,2 mi | -$102,1 mi | -593.9% | -19.0% | -11.8% | 10 |
| RLAYRelay Therapeutics, Inc. | $15,4 mi | -$276,5 mi | · | -41.1% | -28.6% | 6 |
| CGONCG Oncology, Inc. | $4,0 mi | -$161,0 mi | · | -21.7% | · | 3 |
| CRSPCRISPR Therapeutics AG | $3,5 mi | -$581,6 mi | · | -30.2% | +37.3% | 11 |
| DNLIDenali Therapeutics Inc. | $0 | -$512,5 mi | · | -45.7% | · | 10 |
| RVMDRevolution Medicines, Inc. | $0 | -$1,13 bi | · | -58.1% | · | 8 |
| BNTXBioNTech SE | EUR 2,87 bi | -EUR 1,14 bi | -39.6% | -5.9% | +42.9% | 9 |
| IMCRImmunocore Holdings plc | GBP 143,7 mi | -GBP 41,2 mi | -28.7% | -18.3% | · | 5 |
| IOVAIOVANCE BIOTHERAPEUTICS, INC. | $263,5 mi | -$391,0 mi | -148.4% | -55.5% | · | 13 |
| VXRTVaxart, Inc. | $237,3 mi | $16,3 mi | · | 22.3% | +125.8% | 17 |
| DNAGinkgo Bioworks Holdings, Inc. | $170,2 mi | -$312,8 mi | -183.8% | -51.1% | +17.3% | 7 |
| AGENAGENUS INC | $114,2 mi | -$3,1 mi | -2.7% | · | +5.3% | 17 |
| CLLSCellectis S.A. | $72,9 mi | -$67,6 mi | -92.7% | -65.3% | +7.4% | 11 |
| CGENCOMPUGEN LTD | $72,8 mi | $35,3 mi | 48.6% | 44.8% | +105.2% | 14 |
| CHRSCoherus Oncology, Inc. | $42,2 mi | $168,0 mi | 398.4% | · | · | 14 |
| VYGRVoyager Therapeutics, Inc. | $40,4 mi | -$119,7 mi | -296.5% | -48.3% | -25.1% | 11 |
| ALECAlector, Inc. | $21,0 mi | -$142,9 mi | -679.2% | -181.6% | -0.1% | 9 |
| VALNValneva SE | EUR 174,7 mi | -EUR 115,2 mi | -66.0% | · | +9.6% | 7 |
| IPHAInnate Pharma SA | EUR 9,0 mi | -EUR 49,2 mi | -546.1% | · | -33.6% | 9 |
| ADAPYAdaptimmune Therapeutics PLC | $178,0 mi | -$70,8 mi | -39.8% | -275.7% | +175.5% | 11 |
| RGNXREGENXBIO Inc. | $170,4 mi | -$193,9 mi | -113.8% | -107.0% | +2.0% | 13 |
| ATRAAtara Biotherapeutics, Inc. | $120,8 mi | $32,7 mi | · | · | · | 4 |
| STROSUTRO BIOPHARMA, INC. | $102,5 mi | -$191,1 mi | -186.5% | · | +19.1% | 10 |
| FDMT4D Molecular Therapeutics, Inc. | $85,2 mi | -$140,1 mi | · | -27.6% | +44.3% | 7 |
| MGTXMeiraGTx Holdings plc | $81,4 mi | -$114,2 mi | -140.3% | · | +39.2% | 7 |
| AUTLAutolus Therapeutics plc | $75,4 mi | -$287,5 mi | -381.4% | -95.0% | · | 7 |
| BDTXBlack Diamond Therapeutics, Inc. | $70,0 mi | $22,4 mi | 32.0% | 22.9% | · | 5 |
| CSBRCHAMPIONS ONCOLOGY, INC. | $59,4 mi | -$1,2 mi | · | -30.5% | +7.7% | 16 |
| PLXProtalix BioTherapeutics, Inc. | $52,7 mi | -$6,6 mi | -12.5% | -14.4% | -3.5% | 17 |
| FENCFENNEC PHARMACEUTICALS INC. | $44,6 mi | -$9,7 mi | -21.8% | · | · | 14 |
| EDITEditas Medicine, Inc. | $40,5 mi | -$160,1 mi | -395.0% | -198.1% | -14.9% | 10 |
| SGMOQSANGAMO THERAPEUTICS, INC | $39,6 mi | -$122,9 mi | -310.8% | · | -19.7% | 17 |
| CCCCC4 Therapeutics, Inc. | $35,9 mi | -$105,0 mi | -292.1% | -44.4% | · | 5 |
| XFORX4 Pharmaceuticals, Inc | $35,1 mi | -$79,2 mi | -225.6% | -76.0% | · | 8 |
| DTILPRECISION BIOSCIENCES INC | $34,3 mi | -$45,7 mi | -133.4% | -61.5% | +7.1% | 8 |
| LCTXLineage Cell Therapeutics, Inc. | $14,6 mi | -$63,5 mi | -435.3% | -103.4% | +51.5% | 17 |
| TSHATaysha Gene Therapies, Inc. | $9,8 mi | -$109,0 mi | -1115.3% | -68.5% | · | 4 |
| CRISCURIS INC | $9,4 mi | -$7,6 mi | -80.3% | · | -2.7% | 17 |
| EVAXEvaxion A/S | $7,5 mi | -$7,7 mi | -102.4% | · | · | 4 |
| FATEFATE THERAPEUTICS INC | $6,6 mi | -$136,3 mi | · | -51.8% | -26.7% | 14 |
| DBVTDBV Technologies S.A. | $5,6 mi | -$146,9 mi | · | -149.8% | -13.0% | 7 |
| ZEOXZeo ScientifiX, Inc. | $5,2 mi | -$5,5 mi | · | · | +11.2% | 15 |
| PRMEPrime Medicine, Inc. | $4,6 mi | -$201,1 mi | · | -146.8% | · | 6 |
| OCGNOcugen, Inc. | $4,4 mi | -$67,8 mi | · | · | · | 12 |
| SRZNSurrozen, Inc. | $3,5 mi | -$242,0 mi | · | · | · | 5 |
| DYAIDYADIC INTERNATIONAL INC | $3,1 mi | -$7,4 mi | -238.3% | -397.8% | +14.0% | 9 |
| OTLKOutlook Therapeutics, Inc. | $1,4 mi | -$62,4 mi | · | · | · | 6 |
| PLURPluri Inc. | $1,0 mi | -$23,8 mi | · | · | · | 13 |
| IMAImageneBio, Inc. | $800.000 | -$45,3 mi | · | · | -38.6% | 6 |
| CRDFCardiff Oncology, Inc. | $593.000 | -$45,9 mi | · | -71.5% | +10.1% | 15 |
| ATYRaTYR PHARMA INC | $190.000 | -$74,1 mi | · | -107.8% | · | 7 |
| ZIVOZivo Bioscience, Inc. | $157.220 | -$13,4 mi | · | · | · | 14 |
| VIVSVivoSim Labs, INC. | $131.000 | -$13,8 mi | · | · | · | 15 |
| AIMAIM ImmunoTech Inc. | $88.000 | -$14,0 mi | · | · | -11.6% | 17 |
| INMBInmune Bio, Inc. | $50.000 | -$45,9 mi | · | -165.2% | +35.4% | 8 |
| ENTXEntera Bio Ltd. | $42.000 | -$11,4 mi | · | -108.0% | · | 6 |
| CKDXFOpthea Ltd | $25.000 | -$162,8 mi | · | · | -15.8% | 7 |
| CELZCREATIVE MEDICAL TECHNOLOGY HOLDINGS, | $6.000 | -$6,0 mi | · | -86.5% | -48.4% | 16 |
| ALLOAllogene Therapeutics, Inc. | $0 | -$190,9 mi | · | -53.4% | · | 7 |
| APTOFAptose Biosciences Inc. | $0 | -$25,5 mi | · | · | · | 6 |
| BCDABioCardia, Inc. | $0 | -$8,2 mi | · | -950.1% | · | 13 |
| CMPXCompass Therapeutics, Inc. | $0 | -$66,5 mi | · | -41.3% | · | 3 |
| ELOXEloxx Pharmaceuticals, Inc. | $0 | -$6,0 mi | · | · | · | 7 |
| PALIPALISADE BIO, INC. | $0 | -$16,8 mi | · | -24.5% | · | 15 |
| PMCBPharmaCyte Biotech, Inc. | $0 | -$19,4 mi | · | -45.6% | · | 16 |
| SRRKScholar Rock Holding Corp | $0 | -$377,9 mi | · | -123.1% | · | 6 |
| ABPOAbpro Holdings, Inc. | · | -$2,9 mi | · | · | · | 2 |
| AGTXAgentix Corp. | · | -$485.636 | · | · | · | 5 |
| ALGSAligos Therapeutics, Inc. | · | -$24,2 mi | · | · | · | 5 |
| AURAAura Biosciences, Inc. | · | -$106,2 mi | · | -73.5% | · | 0 |
| BCABBioAtla, Inc. | · | -$59,6 mi | · | · | · | 1 |
| CABACabaletta Bio, Inc. | · | -$167,9 mi | · | -127.0% | · | 0 |
| CGEMCullinan Therapeutics, Inc. | · | -$219,9 mi | · | -44.0% | · | 3 |
| CVMCEL SCI CORP | · | -$25,4 mi | · | -176.3% | · | 4 |
| ENGNenGene Therapeutics Inc. | · | -$117,3 mi | · | -53.3% | · | 0 |
| IKTInhibikase Therapeutics, Inc. | · | -$48,3 mi | · | -36.0% | · | 3 |
| MOLNMOLECULAR PARTNERS AG | CHF 0 | -CHF 61,7 mi | · | -55.5% | · | 7 |
| SLDBSolid Biosciences Inc. | · | -$174,3 mi | · | -109.9% | · | 7 |
| VISKViskase Holdings, Inc. | · | -$3,4 mi | · | · | · | 15 |
| WINTWINDTREE THERAPEUTICS INC | · | -$1,8 mi | · | -26.7% | · | 8 |
| GLUEMonte Rosa Therapeutics, Inc. | $123,7 mi | -$38,6 mi | -31.2% | -16.9% | · | 3 |
| IPSCCentury Therapeutics, Inc. | $109,2 mi | -$9,6 mi | -8.8% | -6.0% | · | 4 |
| IVVDInvivyd, Inc. | $53,4 mi | -$52,5 mi | -98.2% | -34.0% | · | 3 |
| SCLXScilex Holding Co | $30,3 mi | -$374,1 mi | -1236.4% | · | +5.1% | 6 |
| MGXMetagenomi Therapeutics, Inc. | $25,2 mi | -$87,9 mi | -348.5% | -44.7% | · | 3 |
| ELUTELUTIA INC. | $12,3 mi | $53,4 mi | 434.2% | · | -22.0% | 7 |
| CRBUCaribou Biosciences, Inc. | $11,2 mi | -$148,1 mi | -1327.4% | -79.0% | -2.0% | 7 |
| TCRXTScan Therapeutics, Inc. | $10,3 mi | -$129,8 mi | -1256.8% | -71.3% | +56.9% | 6 |
| INBXInhibrx Biosciences, Inc. | $1,3 mi | -$140,1 mi | · | -197.8% | · | 3 |
| PROKPROKIDNEY CORP. | $893.000 | -$69,0 mi | · | · | · | 4 |
| SNTISenti Biosciences Holdings, Inc. | $22.000 | -$61,4 mi | · | -393.4% | · | 5 |
| ARTVArtiva Biotherapeutics, Inc. | $0 | -$83,9 mi | · | -56.5% | · | 3 |
| SABSSAB Biotherapeutics, Inc. | $0 | $13,3 mi | · | 15.0% | · | 6 |
| CADLCandel Therapeutics, Inc. | · | -$38,2 mi | · | -64.6% | · | 3 |
"·" marca uma cifra que não está nos nossos dados.